Piperazines
"Piperazines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D010879
|
MeSH Number(s) |
D03.383.606
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Piperazines".
Below are MeSH descriptors whose meaning is more specific than "Piperazines".
This graph shows the total number of publications written about "Piperazines" by people in this website by year, and whether "Piperazines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1980 | 1 | 0 | 1 | 1981 | 2 | 0 | 2 | 1987 | 1 | 0 | 1 | 1991 | 0 | 1 | 1 | 1992 | 2 | 1 | 3 | 1993 | 1 | 1 | 2 | 1994 | 2 | 0 | 2 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 3 | 1 | 4 | 2002 | 8 | 1 | 9 | 2003 | 11 | 5 | 16 | 2004 | 6 | 6 | 12 | 2005 | 5 | 6 | 11 | 2006 | 3 | 5 | 8 | 2007 | 9 | 2 | 11 | 2008 | 6 | 4 | 10 | 2009 | 7 | 7 | 14 | 2010 | 9 | 5 | 14 | 2011 | 9 | 7 | 16 | 2012 | 5 | 4 | 9 | 2013 | 5 | 4 | 9 | 2014 | 4 | 1 | 5 | 2015 | 0 | 1 | 1 | 2017 | 4 | 1 | 5 | 2018 | 3 | 4 | 7 | 2019 | 5 | 4 | 9 | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Piperazines" by people in Profiles.
-
Chaekal OK, van Besien K. Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected? Leuk Lymphoma. 2020 12; 61(12):2783-2784.
-
Hammel P, Kindler HL, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Joo S, Yoo HK, Patel N, Golan T. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. Ann Oncol. 2019 12 01; 30(12):1959-1968.
-
Golan T, Locker GY, Kindler HL. Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply. N Engl J Med. 2019 10 10; 381(15):1492-1493.
-
Agarwal S, Chang DW. Breast reconstruction in the patient with stable, metastatic breast cancer. Breast J. 2020 02; 26(2):335-336.
-
Strohbehn GW, Vokes EE. Palbociclib: a new partner for cetuximab? Lancet Oncol. 2019 09; 20(9):1195-1196.
-
Hegab AE, Ozaki M, Kameyama N, Gao J, Kagawa S, Yasuda H, Soejima K, Yin Y, Guzy RD, Nakamura Y, Ornitz DM, Betsuyaku T. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts. J Pathol. 2019 10; 249(2):193-205.
-
Aggarwal C, Redman MW, Lara PN, Borghaei H, Hoffman P, Bradley JD, Newman AJ, Feldman MJ, Minichiello K, Miao J, Mack PC, Papadimitrakopoulou VA, Herbst RS, Kelly K, Gandara DR. SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy). J Thorac Oncol. 2019 10; 14(10):1847-1852.
-
Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL. Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. N Engl J Med. 2019 07 25; 381(4):317-327.
-
Liu JF, Barry WT, Birrer M, Lee JM, Buckanovich RJ, Fleming GF, Rimel BJ, Buss MK, Nattam SR, Hurteau J, Luo W, Curtis J, Whalen C, Kohn EC, Ivy SP, Matulonis UA. Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer. Ann Oncol. 2019 04 01; 30(4):551-557.
-
Grippo AJ, McNeal N, Watanasriyakul WT, Cacioppo S, Scotti ML, Dagner A. Behavioral and cardiovascular consequences of disrupted oxytocin communication in cohabitating pairs of male and female prairie voles. Soc Neurosci. 2019 12; 14(6):649-662.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|